<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-051044</identifier>
<setSpec>0213-005X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Expert recommendations for the diagnosis and treatment of chronic hepatitis C infection in the prison setting</dc:title>
<dc:description xml:lang="en">The prevalence of HCV infection in Spanish prisons is very high (38.5%). The characteristics of the infected patients, particularly the high rate of HIV coinfection, makes it very likely that the morbidity and mortality produced by serious liver disease secondary to this infection will increase considerably in the coming years. A group of Spanish experts with experience in patients who are inmates has been invited to establish a series of recommendations for the diagnosis and treatment of chronic hepatitis C infection in Spanish prisons (AU)</dc:description>
<dc:creator>Teixidó i Pérez, Nuria</dc:creator>
<dc:creator>Portilla-Sogorb, Joaquín</dc:creator>
<dc:creator>Saiz de la Hoya-Zamácola, Pablo</dc:creator>
<dc:creator>Boix-Martínez, Vicente</dc:creator>
<dc:creator>Reus-Bañuls, Sergio</dc:creator>
<dc:creator>Núñez-Martínez, Óscar</dc:creator>
<dc:creator>Marco-Mouriño, Andrés</dc:creator>
<dc:creator>Clemente-Ricote, Gerardo</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La prevalencia de la infección por el virus de la hepatitis C (VHC) en las prisiones españolas es muy elevada (38,5%). Las características de los pacientes infectados, especialmente la elevada coinfección con el virus de la inmunodeficiencia humana (VIH), hacen probable que la morbilidad y mortalidad producida por enfermedad hepática grave secundaria a esta infección aumente de forma considerable en los próximos años. Un grupo de expertos multidisciplinar con experiencia con pacientes internados en prisiones españolas ha sido invitado a establecer una serie de recomendaciones para el diagnóstico y tratamiento de la hepatitis C en las prisiones españolas (AU)</dc:description>
<dc:source>Enferm Infecc Microbiol Clin;24(9): 568-575, nov. 2006. tab</dc:source>
<dc:identifier>ibc-051044</dc:identifier>
<dc:title xml:lang="es">Recomendaciones de expertos sobre el diagnóstico y tratamiento de la hepatitis C crónica en el medio penitenciario</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d24718^s22046</dc:subject>
<dc:subject>^d33344^s22046</dc:subject>
<dc:subject>^d33344^s22057</dc:subject>
<dc:subject>^d11765</dc:subject>
<dc:subject>^d1731^s22074</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d29416^s22001</dc:subject>
<dc:subject>^d30291</dc:subject>
<dc:subject>^d24572^s22066</dc:subject>
<dc:subject>^d29469^s22073</dc:subject>
<dc:subject>^d31852^s22001</dc:subject>
<dc:subject>^d12663^s22073</dc:subject>
<dc:subject>^d11766^s22083</dc:subject>
<dc:type>article</dc:type>
<dc:date>200611</dc:date>
</metadata>
</record>
</ibecs-document>
